search.noResults

search.searching

dataCollection.invalidEmail
note.createNoteMessage

search.noResults

search.searching

orderForm.title

orderForm.productCode
orderForm.description
orderForm.quantity
orderForm.itemPrice
orderForm.price
orderForm.totalPrice
orderForm.deliveryDetails.billingAddress
orderForm.deliveryDetails.deliveryAddress
orderForm.noItems
Infection Control & Hospital Epidemiology


followed by prospective data mining of the EHR to rapidly iden- tify potential outbreaks and their routes of transmission. The pur- pose of this study was to develop and validate data mining tools using retrospective outbreaks, with the ultimate goal of utilizing these tools as a component of EDS-HAT.


Methods Study setting


This study was conducted at the University of Pittsburgh Medical Center-Presbyterian Hospital (UPMC), an adultmedical and surgical tertiary-care hospital with 762 total beds, 150 critical care unit beds, >32,000 yearly inpatient admissions, and >400 solid organ transplants per year. The UPMC eRecord EHR systemhas >29,000 active users, including >5,000 physicians affiliated with UPMC, and it comprises >3.6 million unique electronic patient records. UPMC uses Cerner Millenium PowerChart (Cerner, Kansas City, MO) and EpicCare (Epic Systems, Madison WI) as the backbone of its inpatientandoutpatientEHRsystems, respectively.TheUniversity of Pittsburgh Institutional Review Board approved this study.


Characterization of retrospective outbreaks from 2011 to 2016


The subject of this study were outbreaks that occurred during 2011–2016 and that had been previously characterized using molecular typing and traditional epidemiologic methods to iden- tify the transmission route. The routine infection prevention prac- tice at the time was to notify the Microbial Genomic Epidemiology Laboratory (MiGEL) of suspected outbreaks caused by bacterial pathogens so that molecular subtyping could be performed. For each patient suspected of being included in the outbreak, the bac- terial isolate was obtained from the clinical microbiology labora- tory. For Clostridium difficile, which is diagnosed at our institution by culture-independent diagnostic testing, the nucleic acid amplification test–positive stool specimen was cultured for C. difficile. For identification of the common exposure responsible for individual outbreaks, our infection prevention teamanalyzed the health records of patients included in the outbreak to identify the responsible routes of transmission (eg, shared locations/staff, shared procedures/operations, or shared medications). Some outbreak investigations utilized environmental or device cultures to confirm the route of transmission. The transmission route defined by infec- tion prevention was used as the gold standard for comparison with transmission routes identified by the data mining algorithm. During the study period, our primary method for molecular


characterization of bacterial isolates was pulsed-field gel electro- phoresis (PFGE). To be considered part of the outbreak, patient isolates had to have 85% band similarity by PFGE. In 2016, WGSreplaced PFGE. Based on our experience usingWGSfor hos- pital outbreaks, a cutoff of ≤20 single-nucleotide polymorphisms (SNPs) was used to define genetically related patient isolates.


Extraction and processing of EHR data for data mining


All inpatient, emergency room, and same-day surgery encounters between January 1, 2011, and December 31, 2016, were identified through anEHR data repository that accepts data from Cerner and EpiCare as full-text medical records and integrates information from central transcription, laboratory, pharmacy, finance, admin- istrative, and other departmental databases.10 For each encounter, we obtained microbiology reports and charge transactions from the data repository. To maintain patient confidentiality, a research


315


database was established in which each patient was assigned a study identification number (ID) using De-ID software (De-ID Data, Philadelphia, PA). Criteria for exemption from informed consent by the university’s institutional review board were met. Charge transaction data are in a data repository as charge codes


that contain patient account numbers, dates of service, cost centers, transaction codes, charge quantities, and charge amounts. Charge codes include any medication, procedure, location, or other billable itemin our hospital and therefore encompass a large number of pos- sible hospital exposures for each patient. Multiple charge codes can represent exposure to a single instrument; therefore, charge codes for key procedures (eg, endoscopic retrograde cholangiopancreatog- raphy [ERCP] and bronchoscopy) were collapsed into a single variable group that represented that exposure. For example, ERCP has 8 Current Procedure Terminology codes: 43260, ERCP diagnostic including collection of specimens; 43261, ERCP with biopsy; 43278, ERCP with ablation of tumors, etc. All were com- bined into a single variable called “ERCP,” although each charge code was also analyzed individually.


Data mining of the electronic health record (EHR)


The data mining program was designed using a case-control approach based upon the genotyping results using patient EHRdata unrelated to the outbreaks as controls.11 Case patients were defined as those who had clinical isolates with the same strain by PFGE or WGS, as defined above. Controls were patients who were hospital- ized during the 30 days before the case patients’ culture date and did not test positive for the genetically related bacterial species. Hospital exposures were then compared for cases and controls. The data mining program was run on all 9 previously identified


outbreaks identified by the infection prevention team at our insti- tution during 2011–2016 to determine the sensitivity of the algo- rithm for identifying the correct transmission route. The transmission route was deemed to be correct if the route was ranked in the 3 most likely routes of transmission and/or had odds ratios>1 with significant P values. Preventable infections were cal- culated based upon a hypothetical 7- or 14-day infection preven- tion intervention from the date of the positive culture assuming that the data mining program had been running in real time and that effective interventions were enacted (eg, removal of con- taminated equipment, disinfection of environment, and/or enhanced precautions). Outbreaks were deemed nonpreventable if there were only 2 isolates in the outbreak. We scored possible common routes of transmission within an


outbreak according to the formula: S ¼ a ln a=r


ðÞþ r a ðÞa ln  ðÞln 1a=r ðÞ; where a is the number of case patients exposed, r is the number


of patients exposed overall (ie, case patients who are part of the outbreak and control patients who are not), and γ is a parameter that balances the positive and negative evidence (γ=1e−4). For a given set of case patients, each patient can be said to have been infected through the hypothesized common route or by intermedi- ate transmission (ie, via transmission from another case patient). If we take θ to be the unknown probability a patient becomes infected upon exposure to the hypothetical route and γ to be the probability a patient is infected by intermediate transmission (ie, by some other means such as patient-to-patient transmission), then the likelihood of observing a particular set of case patients is propor- tional to θb(1 − θ)r-bγ-b, where b is the number of case patients


Page 1  |  Page 2  |  Page 3  |  Page 4  |  Page 5  |  Page 6  |  Page 7  |  Page 8  |  Page 9  |  Page 10  |  Page 11  |  Page 12  |  Page 13  |  Page 14  |  Page 15  |  Page 16  |  Page 17  |  Page 18  |  Page 19  |  Page 20  |  Page 21  |  Page 22  |  Page 23  |  Page 24  |  Page 25  |  Page 26  |  Page 27  |  Page 28  |  Page 29  |  Page 30  |  Page 31  |  Page 32  |  Page 33  |  Page 34  |  Page 35  |  Page 36  |  Page 37  |  Page 38  |  Page 39  |  Page 40  |  Page 41  |  Page 42  |  Page 43  |  Page 44  |  Page 45  |  Page 46  |  Page 47  |  Page 48  |  Page 49  |  Page 50  |  Page 51  |  Page 52  |  Page 53  |  Page 54  |  Page 55  |  Page 56  |  Page 57  |  Page 58  |  Page 59  |  Page 60  |  Page 61  |  Page 62  |  Page 63  |  Page 64  |  Page 65  |  Page 66  |  Page 67  |  Page 68  |  Page 69  |  Page 70  |  Page 71  |  Page 72  |  Page 73  |  Page 74  |  Page 75  |  Page 76  |  Page 77  |  Page 78  |  Page 79  |  Page 80  |  Page 81  |  Page 82  |  Page 83  |  Page 84  |  Page 85  |  Page 86  |  Page 87  |  Page 88  |  Page 89  |  Page 90  |  Page 91  |  Page 92  |  Page 93  |  Page 94  |  Page 95  |  Page 96  |  Page 97  |  Page 98  |  Page 99  |  Page 100  |  Page 101  |  Page 102  |  Page 103  |  Page 104  |  Page 105  |  Page 106  |  Page 107  |  Page 108  |  Page 109  |  Page 110  |  Page 111  |  Page 112  |  Page 113  |  Page 114  |  Page 115  |  Page 116  |  Page 117  |  Page 118  |  Page 119  |  Page 120  |  Page 121  |  Page 122  |  Page 123  |  Page 124  |  Page 125  |  Page 126  |  Page 127  |  Page 128  |  Page 129  |  Page 130  |  Page 131  |  Page 132